Opening new paths in aging research
Calico Life Sciences just deployed AI to connect scattered aging research. Here's what that means for drug discovery timelines.
Why it matters
AI-powered research tools are moving beyond demos into real scientific workflows. Calico's use of Co-Scientist to accelerate aging research shows how enterprises are using AI agents to synthesize findings and generate actionable hypotheses—a direct productivity multiplier in high-stakes domains.
The key facts
10 to knowCalico Life Sciences deploying Co-Scientist for aging research
Use case: connecting scattered findings and generating new research leads
Real-world deployment in pharmaceutical/biotech R&D workflow
Google DeepMind backing (Co-Scientist is DeepMind product)
Demonstrates AI agent application in knowledge synthesis and hypothesis generation
Calico Life Sciences deploying Co-Scientist (Google DeepMind AI tool)
Use case: connecting disparate aging research findings
Application: generating new research leads from existing data
Published by DeepMind (May 2026)
Real-world deployment in biotech/pharma research workflow
Go to the source
Google DeepMind Blogdeepmind.google
Publisher excerpt: Calico Life Sciences uses Co-Scientist to connect scattered findings and generate new leads in aging research.